Cingulate Therapeutics
The Investor Relations website contains information about Cingulate Inc's business for stockholders, potential investors, and financial analysts.
Private Company
Total funding raised: $25M
About
The Investor Relations website contains information about Cingulate Inc's business for stockholders, potential investors, and financial analysts.
Small Molecules
Funding History
3Total raised:$25M
IPOUndisclosed
Series B$15M
Series A$10M